Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-2000 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 217,300 |
| Marketable Securities | 1,136,900 |
| Receivables | 702,700 |
| Inventories | 486,100 |
| TOTAL | $2,650,900 |
| Non-Current Assets | |
| PPE Net | 608,600 |
| Other Non-Current Assets | 711,000 |
| TOTAL | $1,319,600 |
| Total Assets | $3,970,500 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 231,600 |
| Accrued Expenses | 241,200 |
| TOTAL | $1,041,300 |
| Non-Current Liabilities | |
| Long Term Debt | 16,500 |
| TOTAL | $16,500 |
| Total Liabilities | $1,057,800 |
| Shareholders' Equity | |
| Common Shares | 154,100 |
| Retained earnings | 1,759,400 |
| Other shareholders' equity | 45,200 |
| TOTAL | $2,912,700 |
| Total Liabilities And Equity | $3,970,500 |